156 related articles for article (PubMed ID: 15464622)
1. 8-Substituted-9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B.
Carotti A; Stefanachi A; Raviña E; Sotelo E; Loza MI; Cadavid MI; Centeno NB; Nicolotti O
Eur J Med Chem; 2004 Oct; 39(10):879-87. PubMed ID: 15464622
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
Carotti A; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Stefanachi A; Vidal B
J Med Chem; 2006 Jan; 49(1):282-99. PubMed ID: 16392813
[TBL] [Abstract][Full Text] [Related]
3. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
[TBL] [Abstract][Full Text] [Related]
4. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of novel substituted 9-deazaxanthines as A2B receptor antagonists.
Nieto MI; Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Rodríguez-Borges JE; Vidal B
Eur J Med Chem; 2010 Jul; 45(7):2884-92. PubMed ID: 20371139
[TBL] [Abstract][Full Text] [Related]
6. 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor.
Stefanachi A; Brea JM; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Vidal B; Carotti A
Bioorg Med Chem; 2008 Mar; 16(6):2852-69. PubMed ID: 18226909
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI
Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 1-alkyl-8-substituted-3-(3-methoxypropyl) xanthines as putative A(2B) receptor antagonists.
Nieto MI; Balo MC; Brea J; Caamaño O; Cadavid MI; Fernández F; Mera XG; López C; Rodríguez-Borges JE
Bioorg Med Chem; 2009 May; 17(9):3426-32. PubMed ID: 19346133
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
[TBL] [Abstract][Full Text] [Related]
11. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
[TBL] [Abstract][Full Text] [Related]
12. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
[TBL] [Abstract][Full Text] [Related]
13. Structure-affinity relationships of adenosine A2B receptor ligands.
Beukers MW; Meurs I; Ijzerman AP
Med Res Rev; 2006 Sep; 26(5):667-98. PubMed ID: 16847822
[TBL] [Abstract][Full Text] [Related]
14. Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists.
Elzein E; Kalla R; Li X; Perry T; Parkhill E; Palle V; Varkhedkar V; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
Bioorg Med Chem Lett; 2006 Jan; 16(2):302-6. PubMed ID: 16275090
[TBL] [Abstract][Full Text] [Related]
15. Selective, high affinity A(2B) adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthines.
Kalla RV; Elzein E; Perry T; Li X; Gimbel A; Yang M; Zeng D; Zablocki J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1397-401. PubMed ID: 18226896
[TBL] [Abstract][Full Text] [Related]
16. New pyrrolopyrimidin-6-yl benzenesulfonamides: potent A2B adenosine receptor antagonists.
Esteve C; Nueda A; Díaz JL; Beleta J; Cárdenas A; Lozoya E; Cadavid MI; Loza MI; Ryder H; Vidal B
Bioorg Med Chem Lett; 2006 Jul; 16(14):3642-5. PubMed ID: 16697192
[TBL] [Abstract][Full Text] [Related]
17. 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Lambertucci C; Antonini I; Buccioni M; Dal Ben D; Kachare DD; Volpini R; Klotz KN; Cristalli G
Bioorg Med Chem; 2009 Apr; 17(7):2812-22. PubMed ID: 19282184
[TBL] [Abstract][Full Text] [Related]
18. 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Borrmann T; Hinz S; Bertarelli DC; Li W; Florin NC; Scheiff AB; Müller CE
J Med Chem; 2009 Jul; 52(13):3994-4006. PubMed ID: 19569717
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
Varani K; Gessi S; Merighi S; Vincenzi F; Cattabriga E; Benini A; Klotz KN; Baraldi PG; Tabrizi MA; Lennan SM; Leung E; Borea PA
Biochem Pharmacol; 2005 Nov; 70(11):1601-12. PubMed ID: 16219300
[TBL] [Abstract][Full Text] [Related]
20. Development of spin-labeled probes for adenosine receptors.
Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE
J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
